The company is pulling eight product types, including 175,000 units of tubing, 32,000 IV administration sets and 24,400 fluid transfer sets. The reason for the recall is because of a potential leaking issue, which can lead to a delay in therapy, increased risk of bloodstream infection and exposure risk of hazardous drugs.
“There is also the potential for life-threatening situations to occur requiring additional medical intervention,” the FDA post said. The database does not report adverse events.
